Abrar Mir is a Founder and Managing Partner of Quadria Capital, a leading Asian healthcare private equity firm. He is British and mainly lives in Singapore.
Mir started his career at international law firm, CMS Cameron McKenna's London office as a trainee solicitor in its corporate finance practice. In 1995, he joined Salomon Smith Barney London office in its healthcare investment banking division. In 2002, Mir joined as managing director in Bank of America Merrill Lynch's healthcare investment banking division based in London, where he was responsible for building the bank's European and Emerging Markets healthcare franchise. Mir later moved from London to Singapore to join global emerging markets focused financial institution, Religare Capital Markets, as Global Head of Healthcare Investment Banking. There, he was responsible for building the firm's healthcare investment banking franchise across emerging markets, including South and Southeast Asia. Together with Dr. Amit Varma, Mir established Quadria Capital, an Asian healthcare investment firm, with the recent closing of its first investment vehicle, a US$304 million healthcare private equity fund, in June 2015. Quadria Capital's global investor base comprises sovereign wealth funds, institutional investors, healthcare corporates, family offices and development finance institutions such as the International Finance Corporation. In addition to the US$304 million raised in its recent fund, the US development finance institution, Overseas Private Investment Corporation, has also approved commitment of up to US$100 million to Quadria Capital in June 2014. Abrar currently serves on the boards of Quadria Capital Investment Management, Medica Synergie, Soho Global Health, Orilus Investment Holdings and Medisia Investment Holdings
Social impact
Mir is a strong advocate of bringing high quality healthcare at an affordable price to those that need it the most. He regularly speaks at impact investing conferences and is leading a study on effective, scalable business models for low costhealthcare delivery and how these can be adapted across various developing countries.
